TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III Rectal Cancer

NCT04104139 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Rectal Adenocarcinoma
Stage IIA Rectal Cancer AJCC v8
Stage IIB Rectal Cancer AJCC v8
Stage III Rectal Cancer AJCC v8
Stage IIIA Rectal Cancer AJCC v8
Stage IIIB Rectal Cancer AJCC v8
Stage IIIC Rectal Cancer AJCC v8

Interventions

RADIATION: 3-Dimensional Conformal Radiation Therapy
RADIATION: Intensity-Modulated Radiation Therapy
DRUG: Trifluridine and Tipiracil Hydrochloride

Sponsor

OHSU Knight Cancer Institute

Collaborators

Oregon Health and Science University
Taiho Pharmaceutical Co., Ltd.